A Randomized Controlled Trial of a Behavioral Weight Loss Program for Human Immunodeficiency Virus-Infected Patients

Clin Infect Dis. 2017 Jul 1;65(1):154-157. doi: 10.1093/cid/cix238.

Abstract

Obesity compounds the negative health effects of human immunodeficiency virus (HIV) infection. We conducted the first randomized trial of behavioral weight loss for HIV-infected patients (n = 40). Participants randomized to an Internet behavioral weight loss program had greater 12-week weight loss (mean, 4.4 ± 5.4 kg vs 1.0 ± 3.3 kg; P = .02) and improvements in quality of life than controls. Clinical Trials Registration NCT02421406.

Keywords: HIV; adherence; quality of life; weight loss.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Female
  • HIV Infections / complications*
  • HIV Infections / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Overweight / complications*
  • Overweight / epidemiology
  • Overweight / therapy*
  • Patient Compliance
  • Quality of Life
  • Weight Loss / physiology*
  • Weight Reduction Programs / methods*

Associated data

  • ClinicalTrials.gov/NCT02421406